Rapid infectious disease test MPR2019-D02

rapid infectious disease test
rapid infectious disease test
rapid infectious disease test
Add to favorites
Compare this product


for infectious diseases, COVID-19
Tested parameter
Sample type
nasal, laboratory, pharyngeal
Analysis mode
for qPCR, for PCR, for RT-PCR, RT-qPCR, DNA analysis
Other characteristics
self-test, with digital reader
Result display time

Max.: 90 min

60 min

Min.: 30 min


Max.: 100 %

99 %

Min.: 99 %


Product Advantages: 1. Coronavirus universal (N) gene detection + synchronous detection of key mutation sites can simultaneously achieve new coronavirus infection screening and mutant identification. 2. High detection sensitivity, up to 500copies/mL; for composite infected persons,it can detect variant strains as low as 0.1% to 0.01%. 3. Strong specificity, no cross-reactions such as non-specific amplification among different mutations. 4. Compatible with Bioteke rapid nucleic acid extraction technology, nucleic acid-free extraction technology and rapid fluorescence quantitative PCR instrument, and the detection results can be obtained within 45 minutes. Novel Coronavirus 2019-nCoV + S Mutant Nucleic Acid Detection Kit Model - Detection of mutation sites - Mutant MPR2019-D01 - N501Y + HV69-70del - Alpha (B.1.1. 7) - MPR2019-D02 - E484K + K417N - Beta (B.1.351) - MPR2019-D03 - E484K + K417T - Gamma (P.1) - MPR2019-D04 - L452R + E484Q + P681R - Delta (B.1.617)



No catalogs are available for this product.

See all of Bioteke Corporation‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.